These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 8959336)

  • 1. Activin and basic fibroblast growth factor regulate neurogenesis of murine embryonal carcinoma cells.
    Ameerun RF; de Winter JP; van den Eijnden-van Raaij AJ; den Hertog J; de Laat SW; Tertoolen LG
    Cell Growth Differ; 1996 Dec; 7(12):1679-88. PubMed ID: 8959336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells.
    Piek E; Afrakhte M; Sampath K; van Zoelen EJ; Heldin CH; ten Dijke P
    J Cell Physiol; 1999 Aug; 180(2):141-9. PubMed ID: 10395283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of differentiation in P19 embryonal carcinoma cells by the expression of vectors encoding truncated or antisense EGF receptor.
    Wu JX; Adamson ED
    Dev Biol; 1993 Sep; 159(1):208-22. PubMed ID: 8365561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal differentiation in response to epidermal growth factor of transfected murine P19 embryonal carcinoma cells expressing human epidermal growth factor receptors.
    den Hertog J; de Laat SW; Schlessinger J; Kruijer W
    Cell Growth Differ; 1991 Mar; 2(3):155-64. PubMed ID: 2059566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells.
    Yang XM; Park M
    Dev Biol; 1993 Jun; 157(2):308-20. PubMed ID: 8388815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated expression of Wnt family members during neuroectodermal differentiation of P19 embryonal carcinoma cells: overexpression of Wnt-1 perturbs normal differentiation-specific properties.
    Smolich BD; Papkoff J
    Dev Biol; 1994 Nov; 166(1):300-10. PubMed ID: 7958454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel type II activin receptor, type IIA-N, induced during the neural differentiation of murine P19 embryonal carcinoma cells.
    Shoji H; Nakamura T; van den Eijnden-van Raaij AJ; Sugino H
    Biochem Biophys Res Commun; 1998 May; 246(2):320-4. PubMed ID: 9610356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic fibroblast growth factor inhibits p38-mediated cell differentiation and growth inhibition by activin A but not by histone deacetylase inhibitors in CML cells.
    Chen CH; Lin JY; Liu FH; Chang JL; Huang HM
    Ann Hematol; 2008 Mar; 87(3):175-82. PubMed ID: 17929017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bFGF inhibits the activation of caspase-3 and apoptosis of P19 embryonal carcinoma cells during neuronal differentiation.
    Miho Y; Kouroku Y; Fujita E; Mukasa T; Urase K; Kasahara T; Isoai A; Momoi MY; Momoi T
    Cell Death Differ; 1999 May; 6(5):463-70. PubMed ID: 10381633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated activin type II receptor inhibits erythroid differentiation in K562 cells.
    Liu F; Shao LE; Yu J
    J Cell Biochem; 2000 Apr; 78(1):24-33. PubMed ID: 10797563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous retinoic acid receptor beta 2 expression during mesoderm differentiation of P19 murine embryonal carcinoma cells.
    Pratt MA; Crippen CA; Ménard M
    Differentiation; 2000 May; 65(5):271-9. PubMed ID: 10929206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow stromal cells produce and respond to activin A: interactions with basic fibroblast growth factor and platelet-derived growth factor.
    Uchimaru K; Motokura T; Takahashi S; Sakurai T; Asano S; Yamashita T
    Exp Hematol; 1995 Jul; 23(7):613-8. PubMed ID: 7601252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
    Murase Y; Okahashi N; Koseki T; Itoh K; Udagawa N; Hashimoto O; Sugino H; Noguchi T; Nishihara T
    J Cell Physiol; 2001 Aug; 188(2):236-42. PubMed ID: 11424090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural and glial-mediated effects of growth factors acting via tyrosine kinase receptors on luteinizing hormone-releasing hormone neurons.
    Voigt P; Ma YJ; Gonzalez D; Fahrenbach WH; Wetsel WC; Berg-von der Emde K; Hill DF; Taylor KG; Costa ME; Seidah NG; Ojeda SR
    Endocrinology; 1996 Jun; 137(6):2593-605. PubMed ID: 8641214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The int-1 proto-oncogene is transcriptionally activated during neuroectodermal differentiation of P19 mouse embryonal carcinoma cells.
    St-Arnaud R; Craig J; McBurney MW; Papkoff J
    Oncogene; 1989 Sep; 4(9):1077-80. PubMed ID: 2674852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoA/ROCK and Cdc42 regulate cell-cell contact and N-cadherin protein level during neurodetermination of P19 embryonal stem cells.
    Laplante I; Béliveau R; Paquin J
    J Neurobiol; 2004 Sep; 60(3):289-307. PubMed ID: 15281068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors.
    De Winter JP; De Vries CJ; Van Achterberg TA; Ameerun RF; Feijen A; Sugino H; De Waele P; Huylebroeck D; Verschueren K; Van Den Eijden-Van Raaij AJ
    Exp Cell Res; 1996 May; 224(2):323-34. PubMed ID: 8612709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid.
    Hamada-Kanazawa M; Ishikawa K; Nomoto K; Uozumi T; Kawai Y; Narahara M; Miyake M
    FEBS Lett; 2004 Feb; 560(1-3):192-8. PubMed ID: 14988021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of activin expression by type beta transforming growth factors.
    van der Kruijssen CM; Feijen A; Huylebroeck D; van den Eijnden-van Raaij AJ
    Exp Cell Res; 1993 Aug; 207(2):407-12. PubMed ID: 8344388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.